ScholarIQanswers from OpenAlex

Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure

PaperCitations, authors & open-access status

Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure have?

ScholarIQcitation count

Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure has 106 citations in the OpenAlex counts ScholarIQ stores.

When was Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure published?

ScholarIQyear

Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure has 2021 year in the ScholarIQ index.

What is the open-access status of Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure?

ScholarIQoa status

Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure has hybrid oa status in the ScholarIQ index.

What is the DOI of Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure?

ScholarIQdoi

The DOI for Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure is on the source record.

What is the PMID of Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure?

ScholarIQpmid

The PMID for Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure is on the source record.

What is the OpenAlex record for Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure?

ScholarIQopenalex

The OpenAlex for Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial